Table 3 Data sources, participants and outcomes
| Method | Participants/recruitment | Sampling | Data collection timing | Outcomes |
|---|---|---|---|---|
| QUANTITATIVE DATA | ||||
| Weekly supervision report | Women included in the cohort study, healthcare workers involved in the screening process at participating facilities | Facilities included in the implementation process | January 2018 to December 2019 |
Implementation outcome Facility-based measure of fidelity |
| Facility routine health information system | Women included in the cohort study, healthcare workers involved in the screening process at participating facilities |
Registries CC screening process (clinical data) HPV testing (laboratory data) | May to December 2019 |
Reach—Number of women screened daily Dose—Screening process time, screening steps |
| Questionnaires (cohort study) | 300 women (150/facility) attending facilities for CC screening and eligible for screening as defined by the project |
Sample size calculated to provide a 5% accuracy in the measurement of screening completeness Based on an expected screening completeness of 80% and to protect against refusal to participate and dropouts, we decided to include 300 women (n = 150 per facility) | July 1st to October 31st, 2019 |
Effectiveness outcomes Screening completeness Screening process satisfaction: postsampling, postresult and post-VIA if applicable Implementation outcomes Individual measure of fidelity Screening steps Context Women’s characteristics |
| QUALITATIVE DATA | ||||
| Observations | Women attending facilities for CC screening, healthcare workers involved in the screening process (90 medical visits, 30 laboratory procedures) |
Screening activities at facilities Waiting room Screening room Laboratories Performed until saturation is obtained | July 1st to August 31st 2019 |
CC screening practice Adaptation performed by healthcare workers |
| Semistructured interviews | 20 Women included in the cohort study, 20 healthcare workers involved in the CC screening process | Maximum variation sampling was used to achieve a diverse sample of providers of various qualifications, sexes and seniorities (n = 08 per facility) for individual in-depth interviews. The same method was used to obtain a diverse sample of 20 women in terms of age, religion, ethnicity, and HPV status (n = 10 per facility) | September 1st to November 20th 2019 |
Women’s CC knowledge, Motivation to undergo screening Experience with HPV-based screening Healthcare workers’ reasons for program adaptation |